Background: Perforin is a cytolitic mediator produced by cytotoxic T cells (CD8+ cells) and
INTRODUCTION

Cytotoxic T cells (CTL)
We have reported that the liposome-mediated ex vivo intracoronary IL-10 gene transfer induced localized IL-10 overexppression and immunosuppression without conventional immunosuppressive regimen, and prolonged cardiac allograft survival (11, 21) . In this model, cytotoxicity of infiltrative T cell was significantly decreased (11,21). The rate of apoptotic myocytes was significantly decreased, but the rate of apoptotic infiltrative CD3+, CD4+ and CD8+ cells was significantly increased (17,28). Fas/FasL pathway involved in more than half of the infiltrative T cell apoptosis (28). In this study, we further tested the hypothesis that the production of Perforin might be affected by the IL-10 gene therapy and play a role in the suppression of CD8+ T cell cytotoxic function and improving cardiac allograft function.
MATERIALS AND METHODS
Liposome-IL-10 gene complex preparation
The IL-10-plasmid (pSVIL-10) containing human recombinant IL-10 cDNA coupled with the simian virus 40 (SV40) early promoter was used (11,21). The construct was complexed with a novel cationic liposome compound. The new generation of the cationic liposome GAP:DLRIE (kindly provided by GIBCO-BRL) has typical of the 2,3-dioxy-propaniminium class of cationic lipids basic skeleton that also included 
Heart transplantation model and intracoronary ex vivo IL-10 gene transfer
A functional cervical heterotopic allograft heart transplant model developed in our laboratory was used (17,21). The advantages of this functional heart model compared with the conventional vascularized non-working model are (1) the left heart is filled with only oxygenated blood; (2) both ventricles can have sufficient preload. Therefore, we can have more physiological condition with this model. New Zealand White donor rabbits weighing 3.5 (Charles River Laboratory, St. Constant, Quebec, Canada) and recipients weighing 4 kg (Irish Farms, Norco, California) were prepared. Anesthesia was induced intravenously with ketamine (10 mg/kg) and acepromazine (1 mg/kg) and maintained with inhaled 2% isoflurane in 100% oxygen via mechanical ventilation (Servo ventilator). After administration of heparin (200 IU/kg) to donor rabbit, cannula was inserted through the right carotid artery for cardioplegia and gene infusion. Venous return to donor heart was occluded by ligation of superior and inferior venae cavae, and then the pulmonary artery was transected. After aorta was clamped at a distal side of the left carotid artery, University of Wisconsin (UW) solution (4℃, 100ml) was injected into the cannula and topical cooling with ice slush was applied.
Left atrium was opened for left ventricular decompression. After coronary beds were washed out completely, pulmonary veins were ligated. Then heart was excised and placed in cold (4℃) UW solution. Liposome IL-10 gene complexes with 10ml normal saline were administered by continuously ex vivo intracoronary infusion at 20ml/hr to the donor heart in the IL-10 gene therapy group. The empty liposome preparation was infused in the control group. Donor heart was then transplanted to the recipient rabbits at the heterotopic right cervical position. The aorta and the left atrium of the donor were anastomosed to the right carotid artery of recipient, and the pulmonary artery and the right atrium of the donor heart were anastomosed to the right jugular vein of recipient, respectively. Topical cooling of the donor heart was maintained throughout the whole procedure. All allografts started beating spontaneously within several minutes after reperfusion. All animal experimental protocols received approval from Institutional Board of Animal Research Committee.
Comparative RT-PCR Analysis
Comparative reverse transcription-polymerase chain reaction (RT-PCR) was performed to detect the transgene expression of hIL-10 in cardiac allograft using the primers and methods described previously (7) . Three competitive templates (CT) were constructed for hIL-10 and housekeeping gene GAPDH respectively. The amplification product of each CT differs in size from the original cDNA product of 70-170 bp. To control for the efficiency of individual RT reactions from which sample cDNA templates were drawn, the same amplification technique was used first to measure the expression of the housekeeping gene GAPDH. Samples of hIL-10 cDNA equivalent to 50 ng total RNA from each individual RT reaction products were diluted appropriately to contain equal concentrations of CT cDNA, normalized to the expression of GAPDH in the sample. For each particular gene, 5 µl of the normalized RT product were coamplified with the constant amount of the gene-specific CT DNA. The relative amounts of testing gene cDNA in the various samples were determined by comparing their respective sample ratios of testing gene cDNA/CT DNA multiplied by the constant amount of CT DNA used for the particular gene in the competitive template RT-PCR.
In addition, all samples were normalized against the respective GAPDH cDNA/CT DNA ratio. These normalization controls for the quantity of cDNA loaded in all samples. PCR samples were run on 2% agarose gel. The intensity of ethidium bromide luminescence was measured using Eagle Sight 3.0 Software (Stratagene, La Jolla, CA) to obtain digital-image acquisition, processing, and analysis system. This software provides an analysis of the relative densities of gel images, which represent two-dimensional arrays of pixels. Gel images were further analyzed and quantified using NIH Image 1.54 program.
ELISA
We used the standard Pharmingen protocol for sandwich ELISA to quantify the amount of hIL-10 in myocardium (28 Frozen sections for Perforin staining were fixed in 100% acetone at 4℃ for 20 minutes.
After rehydration in phosphate-buffer solution (PBS), sections were incubated in PBS with 0.3% hydrogen peroxide for 10 minutes followed by incubation with 1% bovine serum albumin for 20 minutes. They were incubated with monoclonal mouse anti-human Perforin antibody (M7236; DAKO, Glostrup, Denmark) for more than 20 hours at 4℃. They were washed three times with PBS, and stained with same method as CD8+ staining. Slides were counterstained with hematoxylin. Perforin-positive myocytes and CD8+ cells in each total cells in both group were respectively calculated using same observation fields in serial sections.
Western Blot Analysis for Perforin
Assessment of lymphocytic infiltrate cytotoxicity
Splenocytes from donor rabbits as the target cells were isolated at the time of transplant and cultured in 10 ml tissue culture medium consisting of RPMI-1640 supplemented with 10% fetal calf serum, 24 mM HEPES buffer, 4 mM L-glutamine, 400U
penicillin G, and 400µg/ml streptomycin. Target cells were treated with Mitomycin C at a concentration of 50 µg/ml for 60 minutes at 37°C before use, then labeled with 51 Cr (9,10).
Graft infiltrating lymphocytes isolated from transplanted hearts were used as effector cells. 1
x 10 4 labeled target cells (in a volume 100µl) were plated in 96-well plates and co-incubated with a serial dilution of effector cell suspension (100µl), resulting in a range of effector cell to target cell ratios. The plates were incubated overnight at 37°C, then supernatants were collected and counted in Beckman gamma-400. All samples were run in triplicate. Specific lysis was calculated according to the formula: Specific lysis=100X(experimental releasespontaneous release/maximum release -spontaneous release) (11,21).
Hemodynamics of transplanted hearts
To assess cardiac function, the cardiac grafts from both control and treatment groups were underwent transatrial catheterization on POD 0 (about 2 hours after reperfusion), 1-2, 4-5, 7-8 or 27-28 just before sacrifice to quantify atrial and ventricular pressures (17,21). A catheter (20G) was inserted into each atrium, and the tip of each catheter was then threaded into its respective ventricle. The pressure of ventricles, peak positive pressure derivative (+dP/dT), and peak negative pressure derivative (-dP/dT) were recorded on Acq Knowledge software (BIOPAC systems Inc., Santa Barbara, CA).
Statistical Analysis
Statistical analysis was performed by using SYSTAT software. Results of the quantitative studies are expressed as means±SD. Statistical comparisons were performed with unpaired t test, and p values less than 0.05 were regarded as statistically significant. When significant differences were detected in either the one-way or two-way ANOVA.
For survival study, 15 rabbits in control group and 15 rabbits in gene therapy group were included. These rabbits were sacrificed after donor heart beating stopped. For time-course studies, animals were sacrificed at POD, 1-2, 4-5, 7-8, 7 rabbits in each subgroup, total of 21 rabbits in gene therapy group and 21 rabbits in control group were analyzed. In correlation analysis, we included all 21 rabbits from these 3 subgroups in gene therapy group.
In gene therapy group, allograft survival was prolonged, 5 rabbits was sacrificed for determine the time-course of gene expression and gene therapy efficacy. In control group, the mean survival was only 9±2 days, so there was no POD 28 subgroup.
RESULTS
Improvement of the graft survival and rejection score
Liposome-mediated ex vivo intracoronary gene transfer induced localized IL-10 transgene expression only in the donor cardiac allografts, and no measurable ectopic overexpression level in the cardiac allografts (p<0.01, Figure 1C ). As shown in Figure 1D , the total infiltrating lymphocytes was reduced 30±3.7% at POD 7-8 in cardiac allografts of gene therapy group compared with that of control group, and the population of CD3+ infiltrative T cells was reduced 54±4.3% at POD 7-8. The reduction in CD8+ T cell subpopulation was significantly more than that in CD4+ subpopulation (70±4.7l% vs.
56±3.3%, p<0.05). The reduction of CD3+ infiltrative T cells was significantly correlated with IL-10 overexpression level in cardiac allografts (p<0.01, Figure 1E ).
Increase of Apoptotic Infiltrate CD8+ Cells in Cardiac Allografts
In consistent with our previous report, ex vivo IL-10 gene therapy not only significantly reduced the amount of infiltrative CD8+ T cells, the cytotoxicity of the T cell was also reduced 62±5.4% at POD 4-5 and 70±6.7% at POD 7 
Increase of Perforin-Positive CD8+ Cells in Cardiac Allografts
The analysis of the co-localization of immunohistochamical staining of the series sections show that 28±5.4% of CD8+ T cells was Perforin+ in cardiac allografts in control group on POD 1-2 ( Figure 3A,B) . There was no significant difference in percentages of 
Increase of Perforin expression in the cardiac allograft myocardium
Western blot analysis demonstrates that Perforin protein expression was not changed in myocardium from cardiac allografts of gene therapy group compared with that in control group on POD 1-2 ( Figure 4A,B) . On POD 4-5, Perforin expression level was decreased 58±5.3% in the myocardium of cardiac allografts from the gene therapy group (p<0.01).
Perforin expression level was further decreased on POD 7-8, but rebound on POD 27-28. The percentage of Perforin-positive CD8+ cells was inversely correlated with the IL-10 expression level in the myocardium of cardiac allografts in gene therapy group ( Figure 4C ).
Perforin expression level was also inversely correlated with the IL-10 protein expression level in myocardium of cardiac allografts in the gene therapy group ( Figure 4D ).
Correlation of Perforin expression and the T cell cytotoxicity
In consistent with our previous finding, IL-10 gene therapy induced a significant reduction of T cell cytotoxicity in cardiac allografts (11,21). Especially in the early stage, the infiltrative T cell cytotoxicity was reduced 64±4% compared with that in controls and it was remained at the low level on POD 7-8 ( Figure 5A ). However, on POD 28, the cytotoxicity was partially recovered. The cytotoxicity of T cells was significantly correlated with Perforin expression in the myocardium of cardiac allografts from IL-10 gene therapy group (p<0.01,
Figure 5B).
Correlation of Perforin expression and the myocyte apoptosis
IL-10 gene therapy induces a significant reduction in the percentage of apoptotic myocytes on POD 4-5 and 7-8 compared with that in control ( Figure 5C ). However, the highest population of apoptotic cardiac myocytes was observed in the cardiac allografts in gene therapy group at POD 28. IL-10 gene transfer induced down regulation of Perforin expression in the CD8+ T cells significantly correlated with the percentage of apoptotic cardiac myocytes in the cardiac allografts (p<0.01, Figure 5D ).
Correlation of Perforin expression and the function of cardiac allografts
IL-10 gene therapy significantly improved the function of the cardiac allografts. The peak systolic left ventricular pressure was increased from 37±6 mmHg in control group to 88±5 mmHg in gene therapy group on POD 7-9 (p<0.01). As shown in Figure 6A , the Perforin expression in the myocardium was inversely correlated with the cardiac allograft left ventricular peak systolic pressure (p<0.01). The maximal ( Figure 6B ) and minimal values of developed pressure velocity of left ventricles were significantly correlated with Perforin expression level in the myocardium of cardiac allografts treated with IL-10 gene.
DISCUSSION
The present study demonstrates for the first time that exogenous IL-10 overexpression in cardiac allografts downregulates Perforin production by allogenic CD8+ T cells in the acute cardiac allograft rejection.
It has been known that the body's major defense against virus-infected and tumorigenic cells is cytotoxic T lymphocyte (CTL)-mediated cytotoxicity, which also plays a role in autoimmune diseases and transplant rejection (14,15). During CTL-mediated cytotoxicity, CTL granules containing Perforin are exocytosed (5,18). Perforin is a pore-forming protein that facilitates the entry of cytotoxic serine proteases, such as granzymes, into target cells by forming transmembrane channels in target cell membranes (7, 26, 27) . The pore that is formed allows water and salts to pass rapidly into the cell.
With the integrity of the cell membrane destroyed, the cells die rapidly (9). Perforin is primarily expressed in cytotoxic effector T lymphocytes (CTL) and natural killer (NK) cells second IL-10 induces CD8+ T cell apoptosis, these apoptotic CD8+ cells produced less or
were not able to produce any Perforin at all. However, with the current data we are not able to determine which mechanism or both mechanisms were involved. 
